VXRT Vaxart Inc

Aviragen Therapeutics Inc is a bio-pharmaceutical company. It is engaged in developing direct-acting antivirals to treat infections that affect a number of patients. It includes oral, small molecule compounds to treat infectious diseases.

$6.68  +0.14 (2.14%)
As of 05/11/2021 10:22:20 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/19/2013
Outstanding shares:  117,963,912
Average volume:  40,313,252
Market cap:   $849,340,166
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    92243A200
ISIN:        US92243A2006
Sedol:      BYWJD92
Valuation   (See tab for details)
PE ratio:   -16.44
PB ratio:   4.38
PS ratio:   654.32
Return on equity:   -18.76%
Net income %:   -2,547.60%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy